ES2014518A6 - Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada. - Google Patents

Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada.

Info

Publication number
ES2014518A6
ES2014518A6 ES8702873A ES8702873A ES2014518A6 ES 2014518 A6 ES2014518 A6 ES 2014518A6 ES 8702873 A ES8702873 A ES 8702873A ES 8702873 A ES8702873 A ES 8702873A ES 2014518 A6 ES2014518 A6 ES 2014518A6
Authority
ES
Spain
Prior art keywords
sustained release
release composition
active agent
aspirin
admixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8702873A
Other languages
English (en)
Spanish (es)
Inventor
Henry C Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2014518A6 publication Critical patent/ES2014518A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
ES8702873A 1986-10-09 1987-10-08 Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada. Expired - Lifetime ES2014518A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2014518A6 true ES2014518A6 (es) 1990-07-16

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8702873A Expired - Lifetime ES2014518A6 (es) 1986-10-09 1987-10-08 Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada.

Country Status (24)

Country Link
JP (1) JPS63101334A (fr)
KR (1) KR880004801A (fr)
AU (1) AU7942087A (fr)
BE (1) BE1000732A5 (fr)
CA (1) CA1332809C (fr)
CH (1) CH675831A5 (fr)
DE (1) DE3733540A1 (fr)
DK (1) DK527487A (fr)
ES (1) ES2014518A6 (fr)
FI (1) FI874414A (fr)
FR (1) FR2604902B1 (fr)
GB (2) GB8624213D0 (fr)
GR (1) GR871550B (fr)
HU (1) HU201875B (fr)
IL (1) IL84104A0 (fr)
IT (1) IT1221493B (fr)
LU (1) LU87009A1 (fr)
NL (1) NL8702294A (fr)
NO (1) NO874200L (fr)
NZ (1) NZ222083A (fr)
PH (1) PH24227A (fr)
PT (1) PT85880B (fr)
SE (1) SE8703889L (fr)
ZA (1) ZA877617B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
CA2371940C (fr) * 1999-03-31 2008-07-15 Janssen Pharmaceutica N.V. Amidon pregelatinise dans une formulation a liberation regulee
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
SI1803447T1 (sl) * 2004-09-09 2010-01-29 Psicofarma S A De C V Farmacevtski sestavek za zadrĺ˝evano sproĺ äśanje hidralazina in njegova uporaba kot podrpora zdravljenju raka

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル

Also Published As

Publication number Publication date
HUT52958A (en) 1990-09-28
DK527487D0 (da) 1987-10-08
FR2604902B1 (fr) 1991-04-26
LU87009A1 (fr) 1988-05-03
SE8703889D0 (sv) 1987-10-08
SE8703889L (sv) 1988-04-10
IT1221493B (it) 1990-07-06
FI874414A (fi) 1988-04-10
FI874414A0 (fi) 1987-10-07
IT8748469A0 (it) 1987-10-08
DK527487A (da) 1988-04-10
PH24227A (en) 1990-05-04
GB2195893B (en) 1991-05-08
JPS63101334A (ja) 1988-05-06
GB8723515D0 (en) 1987-11-11
ZA877617B (en) 1989-05-30
IL84104A0 (en) 1988-03-31
PT85880B (pt) 1990-07-31
GB8624213D0 (en) 1986-11-12
KR880004801A (ko) 1988-06-27
CA1332809C (fr) 1994-11-01
CH675831A5 (fr) 1990-11-15
PT85880A (en) 1987-11-01
GB2195893A (en) 1988-04-20
GR871550B (en) 1988-02-15
NO874200D0 (no) 1987-10-07
HU201875B (en) 1991-01-28
DE3733540A1 (de) 1988-04-14
NO874200L (no) 1988-04-11
AU7942087A (en) 1988-04-14
BE1000732A5 (fr) 1989-03-21
NL8702294A (nl) 1988-05-02
NZ222083A (en) 1991-05-28
FR2604902A1 (fr) 1988-04-15

Similar Documents

Publication Publication Date Title
ES8607009A1 (es) Un metodo para preparar una forma de dosificacion unitaria solida, terapeuticamente activa
GR3005796T3 (fr)
KR100225493B1 (en) Controlled release matrix for pharmaceuticals
AU3015889A (en) Pharmaceutical granulate
IL106693A (en) Controlled sustained release tablets containing bupropion hydrochloride
ES2026198T3 (es) Compuesto a base de acido valproico solido, estable a la humedad y metodo para su preparacion.
ES2014518A6 (es) Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada.
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
CA2001552A1 (fr) Lyophilizats de cyclophosphamide - bicarbonate de sodium
USD278813S (en) Housing for a telephone stand or similar article
USD313163S (en) Concrete footer form brace
USD275669S (en) Telephone stand or similar keyboard article
SE8704240D0 (sv) Analgesic preparations
USD261575S (en) Combined stool and footrest
ES8200876A1 (es) Procedimiento para preparar ureas
AU7534787A (en) Pharmacologically active compounds and use
Yang THE ARTIFICIAL ORGAN RESEARCH IN CHINA
AU103222S (en) Trestle

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204